Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Leiden University Medical Center
Delfi Diagnostics Inc.
Alpha Biopharma (Jiangsu) Co., Ltd.
Hoffmann-La Roche
Revolution Medicines, Inc.